Company Number: 12717903

Analysis Date: 2025-07-29 16:39 UTC

1. Credit Opinion: DECLINE
   Vitmedics Ltd demonstrates a weak financial position with significant and growing negative net assets and net current liabilities for the past three years. The company’s ability to meet short-term obligations is severely impaired given current liabilities of £30,402 vastly exceed current assets of £544 as at February 2024. There is no evidence of profitability or cash generation, and the minimal share capital (£1) reflects limited equity support. Without a clear turnaround plan or capital injection, the risk of default on credit facilities is high.

2. Financial Strength:
   The balance sheet shows persistently negative net assets (£-30,857) and net current assets (£-29,858) as of the latest accounts. Fixed assets are negligible (£231), and the company relies heavily on creditor financing to fund operations. Shareholders’ funds remain deeply negative, reflecting accumulated losses and no retained earnings. The company’s micro-entity status indicates small scale, but the financial trajectory points to deteriorating financial health rather than stability or growth.

3. Cash Flow Assessment:
   Reported cash balances are minimal (£1 reported previously, with current assets only £544), indicating critically weak liquidity. The large current liabilities suggest urgent cash outflows exceeding inflows, and working capital is highly negative. This suggests an inability to service short-term debts or operational expenses from internal resources. There is no indication of external financing or improved cash flow generation.

4. Monitoring Points:

• Creditor aging and payment default risk
• Changes in current liabilities and working capital position
• Any capital injections or equity financing to improve net asset position
• Cash flow statements or management accounts showing improvements in liquidity
• Business model changes or new revenue streams to reverse losses